Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-16 FREEMAN KEVIN D Director Grant or award · Stock option (right to buy) +60,000 60,000
2025-12-23 FREEMAN KEVIN D Director Purchase +5,500 $3.55 $20K 55,269
2025-12-23 FREEMAN KEVIN D Director Purchase 10b5-1 +5,500 $3.55 $20K 55,269
2025-12-23 FREEMAN KEVIN D Director Purchase 10b5-1 +5,500 $3.55 $20K 55,269
2025-07-17 FREEMAN KEVIN D Director Purchase +5,000 $2.90 $14K 49,769
2025-01-23 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +60,000 60,000
2024-12-24 FREEMAN KEVIN D Director Purchase +10,000 $0.81 $8K 44,769
2024-10-17 FREEMAN KEVIN D Director Purchase +1,300 $2.64 $3K 34,769
2024-10-16 FREEMAN KEVIN D Director Purchase +5,000 $2.70 $14K 33,469
2024-10-16 FREEMAN KEVIN D Director Purchase +5,000 $2.70 $14K 80,000
2024-06-20 FREEMAN KEVIN D Director Purchase +2,500 $2.38 $6K 28,469
2024-04-22 FREEMAN KEVIN D Director Purchase +2,500 $2.98 $7K 25,969
2024-04-09 FREEMAN KEVIN D Director Other acquisition +2,063 18,063
2024-01-24 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-01-26 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-10-28 FREEMAN KEVIN D Director Purchase +10,000 $1.41 $14K 75,000
2022-05-19 FREEMAN KEVIN D Director Purchase +5,000 $1.33 $7K 65,000
2022-04-18 FREEMAN KEVIN D Director Purchase +5,000 $1.71 $9K 60,000
2022-01-24 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-19 FREEMAN KEVIN D Director Purchase +5,000 $1.96 $10K 55,000

Page 1 of 2 · 36 trades